339 related articles for article (PubMed ID: 30176173)
21. Prognostic value of the serum free light chain ratio in newly diagnosed myeloma: proposed incorporation into the international staging system.
Snozek CL; Katzmann JA; Kyle RA; Dispenzieri A; Larson DR; Therneau TM; Melton LJ; Kumar S; Greipp PR; Clark RJ; Rajkumar SV
Leukemia; 2008 Oct; 22(10):1933-7. PubMed ID: 18596742
[TBL] [Abstract][Full Text] [Related]
22. [Analysis of serum levels of Dickkopf-1 (DKK-1) in monoclonal gammopathy of undetermined significance and multiple myeloma].
Ščudla V; Petrová P; Pika T; Lochman P; Minařík J; Bačovský J; Srovnalík K
Cas Lek Cesk; 2015; 154(4):181-8. PubMed ID: 26357861
[TBL] [Abstract][Full Text] [Related]
23. The International Scoring System (ISS) for multiple myeloma remains a robust prognostic tool independently of patients' renal function.
Dimopoulos MA; Kastritis E; Michalis E; Tsatalas C; Michael M; Pouli A; Kartasis Z; Delimpasi S; Gika D; Zomas A; Roussou M; Konstantopoulos K; Parcharidou A; Zervas K; Terpos E;
Ann Oncol; 2012 Mar; 23(3):722-729. PubMed ID: 21652580
[TBL] [Abstract][Full Text] [Related]
24. [Serum level of IL-17 in patients with multiple myeloma and its clinical significance].
Zhang XL; Zhang WH; Fan XH; Wei F; Zhang M
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):930-2. PubMed ID: 22931657
[TBL] [Abstract][Full Text] [Related]
25. Chronic kidney disease stage 5 as the prognostic complement of International Staging System for multiple myeloma.
Hsiao LT; Yang CF; Yang SH; Gau JP; Yu YB; Hong YC; Liu CY; Liu JH; Chen PM; Chiou TJ; Tzeng CH
Eur J Haematol; 2012 Feb; 88(2):159-66. PubMed ID: 21973045
[TBL] [Abstract][Full Text] [Related]
26. Staging systems and prognostic factors as a guide to therapeutic decisions in multiple myeloma.
Kyrtsonis MC; Maltezas D; Tzenou T; Koulieris E; Bradwell AR
Semin Hematol; 2009 Apr; 46(2):110-7. PubMed ID: 19389494
[TBL] [Abstract][Full Text] [Related]
27. Heterogeneity in long-term outcomes for patients with Revised International Staging System stage II, newly diagnosed multiple myeloma.
Schavgoulidze A; Lauwers-Cances V; Perrot A; Cazaubiel T; Chretien ML; Moreau P; Facon T; Leleu X; Karlin L; Stoppa AM; Decaux O; Belhadj K; Arnulf B; Mohty M; Ariette CM; Fohrer-Sonntag C; Lenain P; Marolleau JP; Tiab M; Araujo C; Orsini-Piocelle F; Jaccard A; Roussel M; Benboubker L; Eveillard JR; Dib M; Divoux M; Attal M; Avet-Loiseau H; Corre J
Haematologica; 2023 May; 108(5):1374-1384. PubMed ID: 36172814
[TBL] [Abstract][Full Text] [Related]
28. International Scoring System in Symptomatic Multiple Myeloma: Experience from a Tertiary Care Center.
Sultan S; Irfan SM; Parveen S; Taufiq U
Asian Pac J Cancer Prev; 2016; 17(4):2031-3. PubMed ID: 27221891
[TBL] [Abstract][Full Text] [Related]
29. Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group collaborative project.
Avet-Loiseau H; Durie BG; Cavo M; Attal M; Gutierrez N; Haessler J; Goldschmidt H; Hajek R; Lee JH; Sezer O; Barlogie B; Crowley J; Fonseca R; Testoni N; Ross F; Rajkumar SV; Sonneveld P; Lahuerta J; Moreau P; Morgan G;
Leukemia; 2013 Mar; 27(3):711-7. PubMed ID: 23032723
[TBL] [Abstract][Full Text] [Related]
30. [Clinical Significance of Serum Free Light Chain and Its κ/λ Ratio in Patients with Multiple Myeloma].
Zhao D; Jiang JQ; Lin L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Aug; 27(4):1173-1178. PubMed ID: 31418375
[TBL] [Abstract][Full Text] [Related]
31. The Revised International Staging System Compared to the Classical International Staging System Better Discriminates Risk Groups among Transplant-Ineligible Multiple Myeloma Patients.
Bila J; Jelicic J; Dencic Fekete M; Trajkovic G; Sretenovic A; Perunicic Jovanovic M; Antic D; Mihaljevic B
Oncol Res Treat; 2017; 40(10):616-620. PubMed ID: 28950269
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the Revised International Staging System in an independent cohort of unselected patients with multiple myeloma.
Kastritis E; Terpos E; Roussou M; Gavriatopoulou M; Migkou M; Eleutherakis-Papaiakovou E; Fotiou D; Ziogas D; Panagiotidis I; Kafantari E; Giannouli S; Zomas A; Konstantopoulos K; Dimopoulos MA
Haematologica; 2017 Mar; 102(3):593-599. PubMed ID: 27789676
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis and treatment of multiple myeloma in Hunan Province.
Liu F; Cheng Q; Song K; Yu H; Li J; Zhang H; Hu G; Zhou M; Wang J; Ding Z; Luo Z; Peng T; Ding L; Zhao L; Liu J; He Y; Peng H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 47(4):497-504. PubMed ID: 35545345
[TBL] [Abstract][Full Text] [Related]
34. Staging Systems for Newly Diagnosed Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplantation: The Revised International Staging System Shows the Most Differentiation between Groups.
Scott EC; Hari P; Kumar S; Fraser R; Davila O; Shah N; Gale RP; Diaz MA; Agrawal V; Cornell RF; Ganguly S; Akpek G; Freytes C; Hashmi S; Malek E; Kamble RT; Lazarus H; Solh M; Usmani SZ; Kanate AS; Saad A; Chhabra S; Gergis U; Cerny J; Kyle RA; Lee C; Kindwall-Keller T; Assal A; Hildebrandt GC; Holmberg L; Maziarz RT; Nishihori T; Seo S; Kumar S; Mark T; D'Souza A
Biol Blood Marrow Transplant; 2018 Dec; 24(12):2443-2449. PubMed ID: 30142419
[TBL] [Abstract][Full Text] [Related]
35. Tumor load in patients with multiple myeloma: β2-microglobulin levels versus whole-body MRI.
D'Anastasi M; Notohamiprodjo M; Schmidt GP; Dürr HR; Reiser MF; Baur-Melnyk A
AJR Am J Roentgenol; 2014 Oct; 203(4):854-62. PubMed ID: 25247952
[TBL] [Abstract][Full Text] [Related]
36. Abnormal heavy/light chain ratio after treatment is associated with shorter survival in patients with IgA myeloma.
Suehara Y; Takamatsu H; Fukumoto K; Fujisawa M; Narita K; Usui Y; Takeuchi M; Endean K; Matsue K
Cancer Sci; 2017 Feb; 108(2):187-192. PubMed ID: 27889936
[TBL] [Abstract][Full Text] [Related]
37. Scintigraphy with technetium-99m methoxyisobutylisonitrile in multiple myeloma patients: correlation with the International Staging System.
Koutsikos J; Grigoraki V; Athanasoulis T; Velidaki A; Mamoulakis C; Zomas A; Anagnostopoulos N; Georgiou E; Dimopoulos MA; Zerva C
Hell J Nucl Med; 2006; 9(3):177-80. PubMed ID: 17160159
[TBL] [Abstract][Full Text] [Related]
38. The detection of circulating plasma cells may improve the Revised International Staging System (R-ISS) risk stratification of patients with newly diagnosed multiple myeloma.
Galieni P; Travaglini F; Vagnoni D; Ruggieri M; Caraffa P; Bigazzi C; Falcioni S; Picardi P; Mazzotta S; Troiani E; Dalsass A; Mestichelli F; Angelini M; Camaioni E; Maravalle D; Angelini S; Pezzoni V
Br J Haematol; 2021 May; 193(3):542-550. PubMed ID: 33792026
[TBL] [Abstract][Full Text] [Related]
39. Serum N-Glycans: A New Diagnostic Biomarker for Light Chain Multiple Myeloma.
Chen J; Fang M; Zhao YP; Yi CH; Ji J; Cheng C; Wang MM; Gu X; Sun QS; Chen XL; Gao CF
PLoS One; 2015; 10(6):e0127022. PubMed ID: 26075387
[TBL] [Abstract][Full Text] [Related]
40. Nucleic acid based risk assessment and staging for clinical practice in multiple myeloma.
Gupta R; Kaur G; Kumar L; Rani L; Mathur N; Sharma A; Dahiya M; Shekhar V; Khan S; Mookerjee A; Sharma OD
Ann Hematol; 2018 Dec; 97(12):2447-2454. PubMed ID: 30056581
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
